In parallel, levels of complement regulatory proteins CD59, CD46, decay-accelerating factor (DAF), and complement receptor type 1 (CR1) were diminished in ADEs from AD patients, indicating a dysregulated complement system in astrocyte EV cargo [69]. Here, CR1 is linked to Alzheimer disease.